>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • APLD +21.8%, PI +21.5%, ALHC +21.2%, TMDX +16.8%, RSI +16.1%, CVNA +15.9%, ARGX +15%, OMCL +14.5%, EBAY +13.8%, MDXG +13.7%, META +12%, TAL +10.7%, RTO +10.4%, CGNX +10.2%, TFX +10.2%, MOD +9.6%, AMSC +9.3%, CLMB +9.3%, PRLB +8.9%, TENB +8.6%, UDMY +8.4%, CVS +8.4%, MSFT +8.3%, FFIV +8.3% (also Chair Alan J. Higgingson to retire), BBVA +8.3%, UIS +8.1%, WDC +7.9%, WRD +7.9%, VSEC +6.4%, NCLH +6.4%, EVTC +5.6%, CHRW +5.5%, EZPW +5.4%, MYRG +5.4%, CMCSA +5.4%, MMSI +5.3%, KEX +5%, MAS +5%, BIIB +4.6%, FOLD +4.4%, SPOK +4.2%, AUPH +4.2%, KGC +4.1%, LNC +4.1%, PBI +4% (also names new CFO; also increases dividend, repurchase authorization), PTC +3.9%, ALB +3.8%, WAY +3.6%, NTGR +3.6%, COMP +3.6%, RGR +3.5%, BHC +3.4%, HWM +3.3%, TSLX +3.1%, AEM +3.1%, CI +3.1%, SIMO +3%, BIGC +2.9%, GFL +2.8%, FMC +2.7%, CCJ +2.7%, TTMI +2.6% (also CEO to retire), BMY +2.6%, INDV +2.5%, CBZ +2.4%, BWA +2.4%, OWL +2.4%, GEL +2.2%, ETD +2% (also declares special dividend of $0.25/sh), MKL +1.9% (also to sell the renewal rights for its Global Reinsurance business to Nationwide), XYL +1.8%, CNMD +1.7%, SUI +1.6%, MUSA +1.5%, BCPC +1.5%, BTI +1.4%, VAL +1.3%, DINO +1.3%, CP +1.2%, QTWO +1.2%, UL +1.2%, AGI +1.1%, TYL +1%, EEFT +1%,
Other news:
  • AUR +12.6% (expands its commercial operations)
  • TIL +5.5% (noted that ImmuneOnco Biopharmaceuticals, announces preliminary safety and efficacy data from the Phase 2 open-label, multicenter study of IMM2510/AXN-2510 in combination with chemotherapy)
  • CCRD +4.5% (EEFT and CCRD to merge)
  • ONC +2% (announced that the European Medicines Agency has granted PRIority MEdicines (PRIME) designation to the Company's investigational Bruton's tyrosine kinase degrader, BGB-16673)
  • BXMT +1.9% (files mixed securities shelf offering)
  • HWKN +1.8% (increases dividend)
  • BTG +1.8% (to begin underground ops at Fekola Mine)
Analyst comments:
  • TYGO +2% (upgraded to Buy from Neutral at Roth Capital)
  • IONS +0.5% (upgraded to Overweight from Equal Weight at Morgan Stanley)